Radiation response and combination target discovery in a novel model of rectal cancer
<p>Rectal cancer is typically treated with radiotherapy, with or without chemotherapy, prior to surgical resection of the tumour. However, in patients that respond poorly to radiation, tumours largely lack significant immune cells within the surrounding milieu and present with a CAF-rich strom...
Autor principal: | Beach, CJ |
---|---|
Outros Autores: | Leedham, S |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
2024
|
Assuntos: |
Registos relacionados
-
Evaluation of Quality of Life, Depression and Anxiety in Patients with Rectal Cancer Receiving Radiotherapy
Por: Feryal Karaca, et al.
Publicado em: (2020-02-01) -
Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer
Por: Yuanyuan Shen, et al.
Publicado em: (2020-02-01) -
On the trail of CBCT-guided adaptive rectal boost radiotherapy, does daily delineation require a radiation oncologist?
Por: Julien Pierrard, et al.
Publicado em: (2024-12-01) -
Efficacy of radiotherapy in patients with rectal cancer undergoing chemotherapy and surgery: a retrospective study based on the SEER database
Por: WANG Anjun, et al.
Publicado em: (2023-03-01) -
Assessment of Variations in Serum Testosterone, Follicle Stimulating Hormone, and Luteinizing Hormone Levels in Patients Receiving Radiotherapy for Rectal Cancer
Por: Abhishek Krishna, et al.
Publicado em: (2022-04-01)